Home › Trial NCT01632852
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
- Trial IDNCT01632852
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorCSL Limited
- Enrollment30
- Start date2012-07
- ConditionsLeukemia, Myeloid, Acute
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.